Nanomedicine News

RSS

Engineered Nanomaterial Can Help Regulate Chloride Levels in Nerve Cells

A nanomaterial engineered by researchers at Duke can help regulate chloride levels in nerve cells that contribute to chronic pain, epilepsy, and traumatic brain injury.

11 Dec 2012

Journal Vaccine Reports Novavax' Phase I RSV Nanoparticle Vaccine Candidate Results

Novavax, Inc. today announced that the journal Vaccine has published the company's data from its 2011 Phase I clinical trial of its respiratory syncytial virus (RSV) fusion (F) recombinant nanoparticle vaccine candid...

7 Dec 2012

University of Kentucky Researcher Recognized for RNA Nanoparticles Study

University of Kentucky researcher Yi Shu was awarded the Best Poster Presentation at the National Cancer Institute Alliance for Nanotechnology in Cancer's Annual Principal Investigators' Meeting last month.

7 Dec 2012

Femtosecond Crystallography Reveals 3D Structure of Enzyme Linked to Sleeping Sickness

An international team of scientists, using the world's most powerful X-ray laser, has revealed the three dimensional structure of a key enzyme that enables the single-celled parasite that causes African trypanosomiasis (or sleeping sickness) in humans.

From Arizona State University 6 Dec 2012

Fungal Nanoparticles Activate Secretion of Immune-System Stimulant

Arthrobotrys oligospora doesn’t live a charmed life; it survives on a diet of roundworm.

6 Dec 2012

Novel Nanotechnology Holds Hope for Treatment of Pediatric Leukemia

Nanotechnology developed by Delaware scientists could potentially deliver chemotherapy to children in a way that attacks cancer cells without harming healthy cells, greatly reducing side effects.

5 Dec 2012

AOAC Certifies FoodChek’s MICT Nanotechnology Based Listeria spp. Testing

FoodChek Systems Inc. ("FoodChek" or the "Corporation") is very proud to announce that the AOAC Research Institute, the approval body for all U.S. food safety tests, has validated and certified as a Performance Tested Method ("PTM"), FoodChek's patent pending Actero™ Listeria Enrichment Media (License #111201) and the FoodChek™ Listeria spp. Assay Cassette (License #111202).

3 Dec 2012

Genisphere, LIMR Partner to Develop Cancer Nanotherapies

Genisphere and the nonprofit Lankenau Institute for Medical Research (LIMR), which are already making progress together on identifying Inflammatory Bowel Disease biomarkers, have partnered to develop nanotherapeutics targeting cancers and eye diseases.

3 Dec 2012

Nanofiber Synthetic Scaffolds Used in Successful Laryngotracheal Implants

With headlines filled with global turmoil, it is always refreshing to see that, within the realm of biomedical research, national boundaries are being successfully transcended, paving the way for a truly worldwide effort to improve lives.

3 Dec 2012

Selecta Biosciences, Sanofi Collaborate on Development of Antigen-Specific Immunotherapies

Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company developing a new class of synthetic vaccines and immunotherapies, today announced that it has entered into a strategic global collaboration with Sanofi to discover highly targeted, antigen-specific immunotherapies for life-threatening allergies.

29 Nov 2012